secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-08-20T23:59:59+00:00
Accession:  0001824293-25-000126
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio files corporate presentation with no material new disclosures
---------------------------------------------------------------------

- Furnished a corporate presentation dated August 20, 2025 under Regulation FD.
- Presentation provides an overview of GRI Bio's approach to inflammatory diseases.
- No specific financial results, guidance, or material operational updates were disclosed.
- The filing is made under Item 7.01 and is not deemed filed for SEC purposes.
- Ticker: GRI; stock trades on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000126/0001824293-25-000126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000126/val-20250820.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer